SCIENCE AT THE SPEED OF BUSINESS

Our fundamental premise is that innovative methods, analytical rigor, and scientific acumen can be provided in a commercial entity that operates “at the speed of business.” Monument Analytics delivers.

Unparalleled Knowledge Base

One of the most remarkable features of Monument Analytics is its access to consultants with an unparalleled knowledge base. Through its independent consulting services, Monument Analytics leverages this acumen to assist clients developing products and services for the benefit of society.

Top Notch Evidence

By capitalizing on this unparalleled depth and breadth of human capital, Monument Analytics is able to generate the highest quality evidence regarding the safety, effectiveness, and real-world value of the full range of medical processes and technologies; and to use this knowledge to help our clients navigate evermore complex and challenging regulatory and payment environments.

Internationally Renowned Experts

Our Principals and Consultants are internationally renowned for their expertise in areas ranging from epidemiology and biostatistics to clinical fields such as cardiovascular medicine, oncology, and immunology.

G. Caleb Alexander
G. Caleb AlexanderMD, MS
CO-FOUNDER & PRINCIPAL
Jonothan C. Tierce
Jonothan C. TierceCPhil
CO-FOUNDER & PRINCIPAL
William V. Padula
William V. PadulaPhD
PRINCIPAL
Natalie Reid
Natalie ReidPhD, MPH, MBA
DIRECTOR
MEET THE CONSULTING TEAM

Services

Our services are broadly organized into four core capabilities

  • Comparative effectiveness analyses
  • Pharmacovigilance and safety assessments
  • Investigations of drug utilization
  • Risk-benefit appraisals
  • Bayesian, meta-analytic and systematic reviews
  • Patient and clinician preferences
  • Global marketplace and pharmaceutical policy
  • Design and conduct of sophisticated comparative effectiveness, pharmacovigilance, and drug utilization studies
  • Advanced techniques for causal inference, management of missing data, and other statistical analysis
  • Cost-benefit analysis and cost-effectiveness analysis
  • Natural history of disease and resource utilization
  • Systematic economic and quality-of-life reviews
  • Core value dossiers

MA in the News

January 2, 2021
Caleb Alexander

Monument Analytics Co-Founder and Principal Dr. Caleb Alexander was quoted in an article in The Economist titled: “The other epidemic: The Justice Department accuses Walmart of fuelling the opioid crisis.” The article discussed the severity of the ongoing opioid epidemic.

November 27, 2020
Caleb Alexander
Monument Analytics Co-Founder and Principal Dr. Caleb Alexander was quoted in a Politico article titled: “Transition 2020: Biden’s other health crisis: A resurgent drug epidemic” for progress made and hindered in the opioid epidemic by the COVID-19 pandemic.

November 18, 2020
Bill Padula
Monument Analytics Principal Dr. Bill Padula was cited in the USA Today article: “Bedsores kill over 60K people in the US each year. Amid COVID, experts worry more may be at risk” for his concern for increased pressure injuries due to COVID-19 hospitalizations.

November 18, 2020
Bill Padula
Monument Analytics Principal Dr. Bill Padula was cited in the USA Today article: “Coronavirus updates: US reaches 250K COVID deaths; New York City schools to close again; Kentucky toughens restrictions” for his concern that pressure injuries may increase due to COVID-19 hospitalizations.

November 13, 2020
Caleb Alexander
Monument Analytics Principal Dr. Caleb Alexander was quoted in The New York Times Article: “F.D.A. Panel Declines to Endorse Controversial Alzheimer’s Drug” for his participation on the federal panel of experts assessing aducanumab for treatment of Alzheimer’s disease.

SEE ALL NEWS